[The controversial story of the human trypanolytic factor].
Pays
Etienne
E
Vanhollebeke
Benoit
B
D000818:Animals; D000951:Antigens, Neoplasm / Q000502:physiology; D000075944:Apolipoprotein L1; D001053:Apolipoproteins / Q000502:physiology*; D006242:Haptoglobins / Q000502:physiology; D006454:Hemoglobins / Q000502:physiology; D006790:Host-Parasite Interactions / Q000502:physiology*; D006801:Humans; D007113:Immunity, Innate; D008075:Lipoproteins, HDL / Q000502:physiology*; D011956:Receptors, Cell Surface / Q000502:physiology*; D013045:Species Specificity; D014347:Trypanosoma brucei gambiense / Q000502:physiology*; D016833:Trypanosoma brucei rhodesiense / Q000502:physiology*; D014353:Trypanosomiasis, African / Q000097:blood* / Q000469:parasitology
C108666:APOL1 protein, human; D000951:Antigens, Neoplasm; D000075944:Apolipoprotein L1; D001053:Apolipoproteins; C058632:HPR protein, human; D006242:Haptoglobins; D006454:Hemoglobins; D008075:Lipoproteins, HDL; D011956:Receptors, Cell Surface; C434063:TLF1 protein, human; C027079:hemoglobin-haptoglobin receptor